Human Leukemia Inhibitory Fact
or LIF抗体 | Anti-Human Leukemia Inhibitory Factor (LIF) Polyclonal Antibody- 询价
- 辰辉创聚生物
- 中国
- NBAB-139899
- 2025年07月10日
- ELISA, Flow Cytometry, WB
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human Leukemia Inhibitory Factor LIF, protein
- 形态：
liquid
- 保存条件：
Short term 4℃; Long term -20℃.
- 保质期：
见COA
- 库存：
大量
- 供应商：
辰辉创聚生物
- 应用范围：
ELISA, Flow Cytometry, WB
- 靶点：
Human Leukemia Inhibitory Factor LIF
- 抗体英文名：
Anti-Human Leukemia Inhibitory Factor (LIF) Polyclonal Antibody
- 抗体名：
Human Leukemia Inhibitory Factor LIF antibody
- 规格：
100ul; 500ul; 1ml
| 产品信息
品名:NebuSelect™ Anti-Human Leukemia Inhibitory Factor (LIF) Polyclonal Antibody
货号:NBAB-139899
品牌:Nebulabio
规格:100ul; 500ul; 1ml
| 产品描述
| 产品属性
Product Category：Rabbit PAb
Reactivity：Human
Specificity：Human Leukemia Inhibitory Factor LIF
Immunogen：Recombinant Human Leukemia Inhibitory Factor LIF, protein
Isotype：Polyclonal Rabbit IgG
Purification：Protein A & Antigen Affinity Purification
Buffer：0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol.
Conjugate：Unconjugated
Applications：ELISA, Flow Cytometry, WB
Dilution：ELISA 1:2000～1:10000, FC 1:20～1:200, WB 1:500～1:2000
Storage：Store at 4°C for short-term, -20°C for long-term. Avoid repeated freezing and thawing cycles.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Parental Smoking and Childhood Leukemia
may be more due to environmental rather than genetic factors, although genes may play modifying roles. Human and animal studies showed that the development of childhood leukemia is a two-step process that requires a prenatal initiating event(s) plus a postnatal promoting event(s
vary. This chapter summarizes our current knowledge on the human factor H-related proteins. In contrast to factor H, they have no strong complement inhibitory activity, although for some of them regulatory or complement modulatory activity
In Vitro Functional Study of miR-126 in Leukemia
MicroRNAs (miRNAs, miRs) are postulated to be important regulators in various cancers, including leukemia. In a large-scale miRNA expression profiling analysis of 435 human miRNAs in 52 acute myeloid leukemia (AML) samples, we found that miR
技术资料暂无技术资料 索取技术资料
